Elkfork Partners’s BioTelemetry BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
Elkfork Partners's BEAT Position: Q3 2019 in Review
Elkfork Partners increased its BioTelemetry (BEAT) stake by 3.1% in Q3 2019, buying an estimated $10.3K and bringing the position to 7,854 shares worth $320K. The position accounts for 0.01% of the portfolio, ranked #708.
Elkfork Partners first reported a position in BEAT in Q1 2017 and has held it in 11 quarters since. The position peaked at $422K in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.
- Elkfork Partners held 7,854 shares of BioTelemetry worth $320K as of Q3 2019.
- Elkfork Partners bought 238 BioTelemetry shares in Q3 2019, an estimated $10.3K.
- BioTelemetry made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #708 holding.
- Elkfork Partners first reported a position in BioTelemetry in Q1 2017 and has held it in 11 quarters since.
- Elkfork Partners's BioTelemetry position peaked at $422K in Q1 2019.
- 219 funds tracked by Wall St. Rank held BioTelemetry as of Q3 2019.
Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.